Cargando…
Pharmacovigilance of biosimilars - Why is it different from generics and innovator biologics?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239406/ https://www.ncbi.nlm.nih.gov/pubmed/32134006 http://dx.doi.org/10.4103/jpgm.JPGM_651_19 |